Designer drugs: a medicinal chemistry perspective
- PMID: 22092008
- DOI: 10.1111/j.1749-6632.2011.06199.x
Designer drugs: a medicinal chemistry perspective
Abstract
There are numerous medicinal chemistry reports in the literature describing the pharmacological properties of thousands of narcotics, stimulants, hallucinogens, sedative-hypnotic drugs, cannabinoids, and other psychoactive substances as well as synthetic methods for their preparations. This information, while essential for the advancement of science, has been used by clandestine chemists to manufacture and market an endless variety of analogs of so-called designer drugs. In this review, we describe how clandestine chemists used the principles of medicinal chemistry to design molecules, referred to as designer drugs, that elicit the effects of opioids, amphetamine and analogs, cannabinoids, and phencyclidine analogs while circumventing the law.
© 2012 New York Academy of Sciences.
Similar articles
-
Chemistry, pharmacology, and metabolism of emerging drugs of abuse.Ther Drug Monit. 2010 Oct;32(5):544-9. doi: 10.1097/FTD.0b013e3181eea318. Ther Drug Monit. 2010. PMID: 20683389 Review.
-
Emergence and properties of spice and bath salts: a medicinal chemistry perspective.Life Sci. 2014 Feb 27;97(1):9-19. doi: 10.1016/j.lfs.2013.09.026. Epub 2013 Oct 7. Life Sci. 2014. PMID: 24113072 Review.
-
Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine.Dis Mon. 2012 Feb;58(2):38-89. doi: 10.1016/j.disamonth.2011.09.004. Dis Mon. 2012. PMID: 22251899 Review. No abstract available.
-
Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.J Anal Toxicol. 2012 Jul;36(6):360-71. doi: 10.1093/jat/bks047. Epub 2012 May 14. J Anal Toxicol. 2012. PMID: 22586208
-
Designer drugs: a medicinal chemistry perspective (II).Ann N Y Acad Sci. 2021 Apr;1489(1):48-77. doi: 10.1111/nyas.14349. Epub 2020 May 12. Ann N Y Acad Sci. 2021. PMID: 32396701 Review.
Cited by
-
The role of nonmuscle myosin II in polydrug memories and memory reconsolidation.Learn Mem. 2018 Aug 16;25(9):391-398. doi: 10.1101/lm.046763.117. Print 2018 Sep. Learn Mem. 2018. PMID: 30115760 Free PMC article.
-
Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.Psychopharmacology (Berl). 2014 Oct;231(21):4135-44. doi: 10.1007/s00213-014-3557-7. Epub 2014 May 7. Psychopharmacology (Berl). 2014. PMID: 24800892 Free PMC article.
-
Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats.Addict Biol. 2018 Jan;23(1):102-110. doi: 10.1111/adb.12479. Epub 2016 Dec 1. Addict Biol. 2018. PMID: 27910188 Free PMC article.
-
The effect of banning MDPV on the incidence of MDPV-positive findings among users of illegal drugs and on court decisions in traffic cases in Finland.Int J Legal Med. 2015 Jul;129(4):741-9. doi: 10.1007/s00414-015-1184-4. Epub 2015 Apr 2. Int J Legal Med. 2015. PMID: 25833171
-
Nephrotoxic effects of designer drugs: synthetic is not better!Nat Rev Nephrol. 2014 Jun;10(6):314-24. doi: 10.1038/nrneph.2014.44. Epub 2014 Mar 25. Nat Rev Nephrol. 2014. PMID: 24662435 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources